Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Diabetic Kidney Disease and Heart Failure
NCT07442448Phase 4Enrolling by invitation
- Sponsor
- Cathay General Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in heart failure (HF), diabetic kidney disease (DKD), sponsored by Cathay General Hospital. Started Apr 2026; status: enrolling by invitation.
02
Drugs
finerenone
03
Conditions
heart failure (HF)diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07442448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442448.